TherapeuticsMD (TXMD) Enterprise Value: 2010-2025
Historic Enterprise Value for TherapeuticsMD (TXMD) over the last 13 years, with Sep 2025 value amounting to $5.3 million.
- TherapeuticsMD's Enterprise Value fell 62.21% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.5 million, marking a year-over-year decrease of 5877.49%. This contributed to the annual value of $4.9 million for FY2024, which is 75.04% down from last year.
- Latest data reveals that TherapeuticsMD reported Enterprise Value of $5.3 million as of Q3 2025, which was down 27.59% from $7.4 million recorded in Q2 2025.
- In the past 5 years, TherapeuticsMD's Enterprise Value registered a high of $382.1 million during Q1 2021, and its lowest value of -$7.6 million during Q4 2022.
- Its 3-year average for Enterprise Value is $14.6 million, with a median of $14.1 million in 2024.
- In the last 5 years, TherapeuticsMD's Enterprise Value tumbled by 108.87% in 2022 and then surged by 354.61% in 2023.
- Quarterly analysis of 5 years shows TherapeuticsMD's Enterprise Value stood at $86.2 million in 2021, then plummeted by 108.87% to -$7.6 million in 2022, then soared by 354.61% to $19.5 million in 2023, then crashed by 75.04% to $4.9 million in 2024, then crashed by 62.21% to $5.3 million in 2025.
- Its last three reported values are $5.3 million in Q3 2025, $7.4 million for Q2 2025, and $5.0 million during Q1 2025.